The Cerebral and Cognitive Changes After Intermittent Theta Burst Stimulation (iTBS) Treatment for Depression

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age22-65
SponsorUniversity Hospital of North Norway

About this trial

The present project aims to assess the neurocognitive impact of a two-week once-a-day regimen of intermittent theta burst stimulation (iTBS) compared to sham iTBS, when targeting the left dorsolateral prefrontal cortex (LDLPFC) in clinically depressed outpatients. The study investigates the relationships between changes in cerebral measures and cognitive performance on an N-back task in relation to the antidepressive effect following iTBS.

Eligibility criteria

Qualifiers

Patients must meet the diagnostic criteria of at least a moderate depression

The duration of the current depressive episode must have lasted more than 2 weeks but less than 2 years

Drug therapy must have been stable for the last three weeks prior to the first treatment day with iTBS

Patients must volunteer to provide informed consent, be able to follow the treatment schedule and have a satisfactory safety screening for iTBS and MRI

Disqualifiers

The current depressive episode is in the mild range

The current episode fulfills the criteria for a major depressive episode requiring inpatient treatment and/or electroconvulsive therapy,

The current depressive episode is clearly triggered by grief or a recent major stressful life event

Bipolar disorder

Trial design

Treatments tested in this trial

  • Intermittent Theta Burst Stimulation

Treatment groups

50 Participants
are divided into 2 treatment groups

Sponsors and collaborators

University Hospital of North Norway

Lead sponsor

UiT The Arctic University of Norway

Collaborator